Why It Matters

Vita Inclinata is lobbying on three policy fronts where Congress faces urgent decisions directly affecting the company’s market opportunities. Most critically, the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have been frozen since September 2025 due to competing reform proposals, leaving funding suspended and new awards blocked. This creates immediate pressure to resolve disagreements between lawmakers like Senator Joni Ernst, who is pushing caps on lifetime awards, and those like Senator Ed Markey, calling for permanent authorization.

Meanwhile, heightened congressional focus on military helicopter safety following the Reagan National Airport crash creates receptive audiences for the company’s MEDEVAC equipment advocacy, while House committee hearings on OSHA’s regulatory approach open space for discussions about modernizing crane safety standards.

By the Numbers

Vita Inclinata Technologies Inc. has invested approximately $3.1 million in federal lobbying since 2020. In final quarter 2025, the company spent $80,000 on in-house lobbying efforts, marking a shift toward direct representation rather than external firms.

Historically, Vita Inclinata retained multiple external firms—including Nickles Group LLC, Vogel Group LLC, and ACG Advocacy LLC. The the fourth quarter of 2025 filing indicates the company now relies solely on Rakan Buhulaiqa, its registered in-house lobbyist since July 2025.

Most significantly, Vita Inclinata testified directly before the Senate Small Business Committee in March 2025 on SBIR reform, positioning itself as an active participant in shaping federal small business innovation policy.

The Agenda

Vita Inclinata Technologies Inc. is lobbying on five specific issues: defense appropriations, Army MEDEVAC equipment funding, Army National Guard appropriations, SBIR program reforms, and OSHA crane safety regulations.

The company’s focus on defense appropriations and Army MEDEVAC equipment directly supports its Vita Rescue System for helicopter hoist operations. Its SBIR advocacy aligns with the company’s position as an innovative small business, while the OSHA crane safety push supports its Vita Load Navigator industrial crane technology.

These efforts coincide with active congressional legislation, including the Department of Defense Appropriations Act, 2026 (S.2572) and the INNOVATE Act (S.853) pushing SBIR reforms.

Broader Context

Vita Inclinata Technologies’ focus on Army MEDEVAC equipment coincides with intense scrutiny of military helicopter safety following the January 2025 Reagan National Airport collision, which killed 67 people and prompted 33 NTSB safety recommendations.

The SBIR program freeze represents an unprecedented crisis, with Senator Joni Ernst reportedly blocking extension efforts while pushing her reform agenda. On crane safety, the House Education and Workforce Committee held hearings examining OSHA’s regulatory balance, providing a legislative forum for discussing modernized safety standards.

Between The Lines

Vita Inclinata’s timing is strategic. The company’s helicopter safety advocacy aligns with congressional momentum following the Reagan crash, while bills like the Military Helicopter Training Safety Act (H.R.1898) and HOVER Act (S.1869) demonstrate sustained legislative interest.

The company’s March 2025 Senate testimony on SBIR reform gives it direct influence in the reauthorization debate, while House hearings titled "Reclaiming OSHA’s Mission: Ensuring Safety without Overreach" provide forums for advocating modernized crane safety standards.

Competitive Landscape

The report identifies limited competitive lobbying activity. Dynepic Inc. is also lobbying on SBIR program reforms, but no other competitors are identified as lobbying on defense appropriations, military MEDEVAC equipment, or OSHA crane safety regulations.

The Bottom Line

Vita Inclinata Technologies spent $80,000 on in-house lobbying in fourth quarter 2025. The company’s March 2025 Senate testimony demonstrates direct stakeholder engagement beyond traditional lobbying, while registered lobbyist Rakan Buhulaiqa provides technical expertise rather than relying on external firm networks.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article